Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS).
Saved in:
| Title: | Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS). |
|---|---|
| Authors: | Tsintari, Vasileia1 (AUTHOR), Walter, Bianca1 (AUTHOR), Fend, Falko2 (AUTHOR), Overkamp, Mathis2 (AUTHOR), Rothermundt, Christian3 (AUTHOR), Lopez, Charles D.4 (AUTHOR), Schittenhelm, Marcus M.3 (AUTHOR), Kampa-Schittenhelm, Kerstin M.1,5,6 (AUTHOR) Kerstin.kampa-schittenhelm@kssg.ch |
| Source: | BMC Cancer. 7/2/2022, Vol. 22 Issue 1, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
